Eaton Vance Ohio Municipal Income Trust Shares of Beneficial Interest
News
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
Business Wire Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader in DNA-encoded library (DEL) technology, today announced a collaboration agreement focused...\n more…
Evotec Announces Change in Management Board
Accesswire Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024Distribution of responsibilities across other Management Board functions HAMBURG, GERMANY / ACCESSWIRE / September 3...\n more…
EVO Stock Earnings: Evotec Misses EPS, Misses Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nEVO stock results show that Evotec missed analyst estimates for earnings per share and missed on revenue for the second quarter of...\n more…
Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
Accesswire Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book in Discovery - higher share of integrated long-term deals will improve...\n more…
Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Accesswire Key scientific achievements drive the expansion of the pipeline of molecular glue degradersPerformance-based and programme-based payments of in total US$ 75 m to Evotec HAMBURG, GERMANY / ACCESSWIRE...\n more…
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
Accesswire Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / August 8, 2024 / Evotec SE...\n more…